SuperworthAytu Biopharma shares outstanding AYTU
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Mar 31, 2026
- 10.5M
- On a year earlier
- +28.1%
- more shares
Aytu Biopharma had 10.5M diluted shares outstanding on average in Q3 FY26, the quarter to Mar 31, 2026.
That is 28.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2023 | 4.1M | +126% |
| FY2022 | 1.8M | +53% |
| FY2021 | 1.2M | +108% |
| FY2020 | 567.1K | +719% |
| FY2019 | 69.2K | +623% |
| FY2018 | 9.6K | +162% |
| FY2017 | 3.7K | +9543% |
| FY2016 | 38 | +177% |
| FY2015 | 14 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 10.5M | +28% | |
| Q2 FY26 | 10M | +18% | |
| Q1 FY26 | 19.5M | +114% | |
| Q3 FY25 | 8.2M | +48% | |
| Q2 FY25 | 8.5M | +54% | |
| Q1 FY25 | 9.1M | +66% | |
| Q3 FY24 | 5.5M | +48% | |
| Q2 FY24 | 5.5M | +77% | |
| Q1 FY24 | 5.5M | +118% | |
| Q4 FY23 | 4.1M | +126% | |
| Q3 FY23 | 3.7M | +151% | |
| Q2 FY23 | 3.1M | +136% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Aytu Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.